In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001412:Bacillus subtilis / Q000187:drug effects; D001414:Bacitracin / Q000008:administration & dosage; D001419:Bacteria / Q000187:drug effects*; D003016:Clostridium perfringens / Q000187:drug effects; D003352:Corynebacterium / Q000187:drug effects; D006863:Hydrogen-Ion Concentration; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D010400:Penicillin G / Q000008:administration & dosage*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy* / Q000209:etiology; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001414:Bacitracin; D010400:Penicillin G